Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.

Abstract

AIMS To investigate the efficacy of sensor-augmented pump therapy vs. multiple daily injection therapy in patients with suboptimally controlled Type 1 diabetes. METHODS In this investigator-initiated multi-centre trial (the Eurythmics Trial) in eight outpatient centres in Europe, we randomized 83 patients with Type 1 diabetes (40 women) currently treated… (More)
DOI: 10.1111/j.1464-5491.2011.03256.x

Topics

Cite this paper

@article{Hermanides2011SensoraugmentedPT, title={Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.}, author={Jeroen Hermanides and Kirsten N\orgaard and Daniela Bruttomesso and Chantal Mathieu and Anders H Frid and Colin M Dayan and Peter Diem and Catherine Fermon and Iris M E Wentholt and Joost B. L. Hoekstra and J. Hans DeVries}, journal={Diabetic medicine : a journal of the British Diabetic Association}, year={2011}, volume={28 10}, pages={1158-67} }